Company registration number: 04404798 Charity registration number: 1097599 

## Verity The Polycystic Ovaries Self Help Group 

known as 

Verity 

(A company limited by guarantee) 

Annual Report and Financial Statements 

for the Year Ended 31 March 2024 



## **Verity The Polycystic Ovaries Self Help Group** 

## **known as Verity** 

## **Contents** 

|Reference and Administrative Details|1|
|---|---|
|Trustees' Report|2 to 4|
|Accountants' Report|5|
|Statement of Financial Activities|6 to 7|
|Balance Sheet|8 to 9|
|Notes to the Financial Statements|10 to 22|





## **Verity The Polycystic Ovaries Self Help Group** 

## **known as Verity** 

## **Reference and Administrative Details** 

|**Charity Registration Number**|1097599|
|---|---|
|**Company Registration**|04404798|
|**Number**||
||The charity is incorporated in England & Wales.|
|**Registered Office**|74A Station Road East|
||Oxted|
||Surrey|
||RH8 0PG|
|**Accountants**|Smart Accounting & Tax Solutions LLP|
||Chartered Accountants|
||74A Station Road East|
||Oxted|
||Surrey|
||RH8 0PG|



Page 1 



## **Verity The Polycystic Ovaries Self Help Group** 

## **known as Verity** 

## **Trustees' Report** 

The Trustees, who are Directors for the purposes of company law, present the annual report together with the financial statements of the Charitable Company for the year ended 31 March 2024. 

## **Objectives and activities** 

## _**Objects and aims**_ 

The principal activity and objectives of the Company in the year under review was that of the provision of information regarding polycystic ovarian syndrome (PCOS). This is primarily provided as digital booklets, an active social media presence and online webinars. The Charity continued to work with professional organisations on furthering the research, treatment guidelines and wider agenda for PCOS including Monash University, Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society, Women’s Health Coalition in Wales and the European Society for Endocrinology. The Charity maintained international and national collaborations with other patient advocacy groups, and with medical researcher teams as co-applicants on several major research projects. 

## _**Public benefit**_ 

During the year the Charity has reached approximately 34,800 users on Facebook and approximately 29,000 users on Instagram – excluding the reach within our own private Facebook Groups. The website received approximately 38,000 website visits from 28,000 unique users, and we had over 25,000 visits to the Verity blog during the year. Additionally, 160 information packs with digital booklets regarding polycystic ovarian syndrome were distributed to supporters. 

The Trustees confirm that they have complied with the requirements of section 17 of the Charities Act 2011 to have due regard to the public benefit guidance published by the Charity Commission for England and Wales. 

Page 2 



## **Verity The Polycystic Ovaries Self Help Group** 

## **known as Verity** 

## **Trustees' Report** 

## **Trustees and officers** 

The Trustees and officers serving during the year and since the year end were as follows: 

Trustees: R Morman, Chairman C Andrews A J Wilcox N J Smart Secretary: C Andrews 

## **Structure, governance and management** 

## _**Nature of governing document**_ 

This is a Company limited by guarantee of the Members and does not have any share capital. 

The Company was constituted in April 2003 and is governed by its Memorandum and Articles of Association. 

## _**Recruitment and appointment of Trustees**_ 

Supporters are asked annually if they wish to become a Trustee, and are elected by a vote of the members at the Annual General Meeting, or co-opted by the Board, in accordance with the Memorandum and Articles of Association. 

## _**Arrangements for setting key management personnel remuneration**_ 

The Trustees are not remunerated and are only reimbursed for valid expenditure incurred on behalf of Verity, of whom four have been reimbursed for a total of £8,530 (2023 £7,792) during the year. The Charity does not have any staff and all volunteers are only reimbursed for expenses incurred on behalf of the Charity. 

## **Financial instruments** 

## _**Objectives and policies**_ 

The Charity's activities expose it to a number of financial risks including credit risk, cash flow risk and liquidity risk. The use of financial derivatives is governed by the Charity’s policies approved by the Board of Trustees, which provide written principles on the use of financial derivatives to manage these risks. The Charity does not use derivative financial instruments for speculative purposes. 

Page 3 



## **Verity The Polycystic Ovaries Self Help Group** 

## **known as Verity** 

## **Trustees' Report** 

## **Statement of Trustees' responsibilities** 

The Trustees (who are also the directors of Verity The Polycystic Ovaries Self Help Group for the purposes of company law) are responsible for preparing the Trustees' report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice), including FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland". 

Company law requires the Trustees to prepare financial statements for each financial year. Under company law the Trustees must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the charitable company and of the incoming resources and application of resources, including its income and expenditure, of the charitable company for that period. In preparing these financial statements, the Trustees are required to: 

- select suitable accounting policies and apply them consistently; 

- observe the methods and principles in the Charities SORP; 

- make judgements and estimates that are reasonable and prudent; 

- state whether applicable accounting standards, comprising FRS 102 have been followed, subject to any material departures disclosed and explained in the financial statements; and 

- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the charitable company will continue in business. 

The Trustees are responsible for keeping proper accounting records that can disclose with reasonable accuracy at any time the financial position of the charitable company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charitable company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities. 

The Trustees are responsible for the maintenance and integrity of the corporate and financial information included on the charitable company's website. Legislation governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions. 

The annual report was approved by the Trustees of the charity on 7 December 2024 and signed on its behalf by: 

......................................... N J Smart Trustee 

Page 4 



## **Chartered Accountants' Report to the Trustees on the Preparation of the Unaudited Statutory Accounts of Verity The Polycystic Ovaries Self Help Group for the Year Ended 31 March 2024** 

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of Verity The Polycystic Ovaries Self Help Group for the year ended 31 March 2024 as set out on pages 6 to 22 from the company's accounting records and from information and explanations you have given us. 

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW) we are subject to its ethical and other professional requirements which are detailed at http://www.icaew.com/en/members/regulations-standards-and-guidance/. 

This report is made solely to the Board of Directors of Verity The Polycystic Ovaries Self Help Group, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the financial statements of Verity The Polycystic Ovaries Self Help Group and state those matters that we have agreed to state to the Board of Directors of Verity The Polycystic Ovaries Self Help Group, as a body, in this report, in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Verity The Polycystic Ovaries Self Help Group and its board of directors as a body for our work or for this report. 

It is your duty to ensure that Verity The Polycystic Ovaries Self Help Group has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and of Verity The Polycystic Ovaries Self Help Group. You consider that Verity The Polycystic Ovaries Self Help Group is exempt from the statutory audit requirement for the year. 

We have not been instructed to carry out an audit or a review of the accounts of Verity The Polycystic Ovaries Self Help Group. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts. 

...................................... 

Smart Accounting & Tax Solutions LLP Chartered Accountants 74A Station Road East Oxted Surrey RH8 0PG 7 December 2024 

Page 5 



## **Verity The Polycystic Ovaries Self Help Group** 

## **known as Verity** 

## **Statement of Financial Activities for the Year Ended 31 March 2024 (Including Income and Expenditure Account and Statement of Total Recognised Gains and Losses)** 

|**Note**<br>**Income and Endowments from:**<br>Donations and legacies<br>3<br>Investment income<br>6<br>Total income<br>**Expenditure on:**<br>Charitable activities<br>8<br>Other expenditure<br>9<br>Total expenditure<br>Net (expenditure)/income<br>Net movement in funds<br>**Reconciliation of funds**<br>Total funds brought forward<br>Total funds carried forward<br>18|**Unrestricted**<br>**funds**<br>**£**<br>13,929<br>900<br>14,829<br>(55,287)<br>(217)<br>(55,504)<br>(40,675)<br>(40,675)<br>60,489<br>19,814|**Restricted**<br>**funds**<br>**£**<br>60,020<br>-<br>60,020<br>(5,168)<br>-<br>(5,168)<br>54,852<br>54,852<br>22,737<br>77,589|**Total**<br>**2024**<br>**£**<br>73,949<br>900|
|---|---|---|---|
||||74,849|
||||(60,455)<br>(217)|
||||(60,672)|
||||14,177|
||||14,177<br>83,226|
||||97,403|



The notes on pages 10 to 22 form an integral part of these financial statements. Page 6 



## **Verity The Polycystic Ovaries Self Help Group** 

## **known as Verity** 

## **Statement of Financial Activities for the Year Ended 31 March 2024 (Including Income and Expenditure Account and Statement of Total Recognised Gains and Losses)** 

|**Note**<br>**Income and Endowments from:**<br>Donations and legacies<br>3<br>Charitable activities<br>4<br>Other trading activities<br>5<br>Investment income<br>6<br>Total income<br>**Expenditure on:**<br>Raising funds<br>7<br>Charitable activities<br>8<br>Other expenditure<br>9<br>Total expenditure<br>Net income<br>Net movement in funds<br>**Reconciliation of funds**<br>Total funds brought forward<br>Total funds carried forward<br>18|**Unrestricted**<br>**funds**<br>**£**<br>21,696<br>830<br>138<br>522<br>23,186<br>1<br>(7,868)<br>(3,707)<br>(11,574)<br>11,612<br>11,612<br>48,877<br>60,489|**Restricted**<br>**funds**<br>**£**<br>27,450<br>-<br>-<br>-<br>27,450<br>(4,713)<br>-<br>-<br>(4,713)<br>22,737<br>22,737<br>-<br>22,737|**Total**<br>**2023**<br>**£**<br>49,146<br>830<br>138<br>522|
|---|---|---|---|
||||50,636|
||||(4,712)<br>(7,868)<br>(3,707)|
||||(16,287)|
||||34,349|
||||34,349<br>48,877|
||||83,226|



All of the charity's activities derive from continuing operations during the above two periods. The funds breakdown for 2023 is shown in note 18. 

The notes on pages 10 to 22 form an integral part of these financial statements. Page 7 



## **Verity The Polycystic Ovaries Self Help Group** 

## **known as Verity** 

## **(Registration number: 04404798) Balance Sheet as at 31 March 2024** 

|**Note**<br>**Fixed assets**<br>Investments<br>14<br>**Current assets**<br>Debtors<br>15<br>Cash at bank and in hand<br>16<br>**Creditors: Amounts falling due within one year**<br>17<br>**Net current assets**<br>**Net assets**<br>**Funds of the charity:**<br>**Restricted income funds**<br>Restricted funds<br>**Unrestricted income funds**<br>Unrestricted funds<br>**Total funds**<br>18|**2024**<br>**£**<br>1<br>30<br>100,201<br>100,231<br>(2,829)<br>97,402<br>97,403<br>77,589<br>19,814<br>97,403|**2023**<br>**£**<br>1<br>1,629<br>84,126|
|---|---|---|
|||85,755<br>(2,530)|
|||83,225|
|||83,226|
|||22,737<br>60,489|
|||83,226|



The notes on pages 10 to 22 form an integral part of these financial statements. Page 8 



## **Verity The Polycystic Ovaries Self Help Group** 

## **known as Verity** 

## **(Registration number: 04404798) Balance Sheet as at 31 March 2024** 

For the financial year ending 31 March 2024 the charity was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. 

Directors' responsibilities: 

- The members have not required the charity to obtain an audit of its accounts for the year in question in accordance with section 476; and 

- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts. 

The financial statements on pages 6 to 22 were approved by the Trustees, and authorised for issue on 7 December 2024 and signed on their behalf by: 

......................................... N J Smart Trustee 

The notes on pages 10 to 22 form an integral part of these financial statements. Page 9 



## **Verity The Polycystic Ovaries Self Help Group** 

## **known as Verity** 

## **Notes to the Financial Statements for the Year Ended 31 March 2024** 

## **1 Charity status** 

The charity is limited by guarantee, incorporated in England & Wales, and consequently does not have share capital. Each of the Trustees is liable to contribute an amount not exceeding £1 towards the assets of the charity in the event of liquidation. 

The address of its registered office is: 74A Station Road East Oxted Surrey RH8 0PG 

These financial statements were authorised for issue by the Trustees on 7 December 2024. 

## **2 Accounting policies** 

## **Summary of significant accounting policies and key accounting estimates** 

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated. 

## **Statement of compliance** 

The financial statements have been prepared in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice (applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)) (issued in October 2019) - (Charities SORP (FRS 102)), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Companies Act 2006. 

## **Basis of preparation** 

Verity The Polycystic Ovaries Self Help Group meets the definition of a public benefit entity under FRS 102. Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy notes. 

## **Going concern** 

The Trustees consider that there are no material uncertainties about the charity's ability to continue as a going concern nor any significant areas of uncertainty that affect the carrying value of assets held by the charity. 

Page 10 



## **Verity The Polycystic Ovaries Self Help Group** 

## **known as Verity** 

## **Notes to the Financial Statements for the Year Ended 31 March 2024** 

## **Income and endowments** 

All income is recognised once the charity has entitlement to the income, it is probable that the income will be received and the amount of the income receivable can be measured reliably. 

## _**Donations and legacies**_ 

Donations are recognised when the charity has been notified in writing of both the amount and settlement date. In the event that a donation is subject to conditions that require a level of performance by the charity before the charity is entitled to the funds, the income is deferred and not recognised until either those conditions are fully met, or the fulfilment of those conditions is wholly within the control of the charity and it is probable that these conditions will be fulfilled in the reporting period. 

## **Expenditure** 

All expenditure is recognised once there is a legal or constructive obligation to that expenditure, it is probable settlement is required and the amount can be measured reliably. All costs are allocated to the applicable expenditure heading that aggregate similar costs to that category. Where costs cannot be directly attributed to particular headings they have been allocated on a basis consistent with the use of resources, with central staff costs allocated on the basis of time spent, and depreciation charges allocated on the portion of the asset’s use. Other support costs are allocated based on the spread of staff costs. 

## _**Raising funds**_ 

These are costs incurred in attracting voluntary income, the management of investments and those incurred in trading activities that raise funds. 

## _**Charitable activities**_ 

Charitable expenditure comprises those costs incurred by the charity in the delivery of its activities and services for its beneficiaries. It includes both costs that can be allocated directly to such activities and those costs of an indirect nature necessary to support them. 

## **Support costs** 

Support costs include central functions and have been allocated to activity cost categories on a basis consistent with the use of resources, for example, allocating property costs by floor areas, or per capita, staff costs by the time spent and other costs by their usage. 

Page 11 



## **Verity The Polycystic Ovaries Self Help Group** 

## **known as Verity** 

## **Notes to the Financial Statements for the Year Ended 31 March 2024** 

## **Governance costs** 

These include the costs attributable to the charity’s compliance with constitutional and statutory requirements, including accountancy, strategic management and trustees’s meetings and reimbursed expenses. 

## **Taxation** 

The charity is considered to pass the tests set out in Paragraph 1 Schedule 6 of the Finance Act 2010 and therefore it meets the definition of a charitable company for UK corporation tax purposes. Accordingly, the charity is potentially exempt from taxation in respect of income or capital gains received within categories covered by Chapter 3 Part 11 of the Corporation Tax Act 2010 or Section 256 of the Taxation of Chargeable Gains Act 1992, to the extent that such income or gains are applied exclusively to charitable purposes. 

## **Depreciation and amortisation** 

Depreciation is provided on tangible fixed assets so as to write off the cost or valuation, less any estimated residual value, over their expected useful economic life as follows: 

**Asset class** Equipment 

**Depreciation method and rate** 25% reducing balance 

## **Impairment of fixed assets** 

Intangible and tangible fixed assets are reviewed for impairment when changes in circumstances or events indicate that the carrying value of the fixed assets may not be recoverable. An impairment loss is recognised where the recoverable amount is less than the carrying value. 

## **Fixed asset investments** 

Fixed asset investments, other than programme related investments, are included at cost at the balance sheet date. 

## **Trade debtors** 

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business. 

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the charity will not be able to collect all amounts due according to the original terms of the receivables. 

Page 12 



## **Verity The Polycystic Ovaries Self Help Group** 

## **known as Verity** 

## **Notes to the Financial Statements for the Year Ended 31 March 2024** 

## **Cash and cash equivalents** 

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value. 

## **Trade creditors** 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the charity does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities. 

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method. 

## **Fund structure** 

Unrestricted income funds are general funds that are available for use at the Trustees discretion in furtherance of the objectives of the charity. 

Restricted income funds are those donated for use in a particular area or for specific purposes, the use of which is restricted to that area or purpose. 

## **Financial instruments** 

## _**Classification**_ 

Financial assets and financial liabilities are recognised when the charity becomes a party to the contractual provisions of the instrument. 

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the charity after deducting all of its liabilities. 

Page 13 



## **Verity The Polycystic Ovaries Self Help Group** 

## **known as Verity** 

## **Notes to the Financial Statements for the Year Ended 31 March 2024** 

## _**Recognition and measurement**_ 

All financial assets and liabilities are initially measured at transaction price (including transaction costs), except for those financial assets classified as at fair value through profit or loss, which are initially measured at fair value (which is normally the transaction price excluding transaction costs), unless the arrangement constitutes a financing transaction. If an arrangement constitutes a financing transaction, the financial asset or financial liability is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. 

when there exists a legally enforceable right to set off the recognised amounts and the charity intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously. 

Financial assets are derecognised when and only when a) the contractual rights to the cash flows from the financial asset expire or are settled, b) the charity transfers to another party substantially all of the risks and rewards of ownership of the financial asset, or c) the charity, despite having retained some, but not all, significant risks and rewards of ownership, has transferred control of the asset to another party. 

Financial liabilities are derecognised only when the obligation specified in the contract is discharged, cancelled or expires. 

Page 14 



## **Verity The Polycystic Ovaries Self Help Group** 

## **known as Verity** 

## **Notes to the Financial Statements for the Year Ended 31 March 2024** 

## **3 Income from donations and legacies** 

|**Unrestricted**<br>**funds**<br>**General**<br>**£**<br>Donations and legacies;<br>Donations from individuals<br>13,138<br>Gift aid reclaimed<br>791<br>Grants, including capital grants;<br>Grants from other charities<br>-<br>13,929<br>**4 Income from charitable activities**<br>Information packs<br>**5 Income from other trading activities**<br>Trading income;<br>Sales of goods and services|**Restricted**<br>**funds**<br>**£**<br>-<br>-<br>60,020<br>60,020|**Total**<br>**2024**<br>**£**<br>13,138<br>791<br>60,020<br>73,949<br>**Total**<br>**2024**<br>**£**<br>-<br>**Total**<br>**funds**<br>**£**<br>-<br>-|**Total**<br>**2023**<br>**£**<br>12,901<br>2,595<br>33,650|
|---|---|---|---|
||||49,146|
||||**Total**<br>**2023**<br>**£**<br>830|
||||**Total**<br>**2023**<br>**£**<br>138|
||||138|



Page 15 



## **Verity The Polycystic Ovaries Self Help Group** 

## **known as Verity** 

## **Notes to the Financial Statements for the Year Ended 31 March 2024** 

## **6 Investment income** 

|Interest receivable and similar income;<br>Interest receivable on bank deposits<br>**7 Expenditure on raising funds**<br>**a) Costs of trading activities**<br>Costs of goods sold<br>Revaluation of investment in subsidiary|**Unrestricted**<br>**funds**<br>**General**<br>**£**<br>900|**Total**<br>**2024**<br>**£**<br>900<br>**Total**<br>**2024**<br>**£**<br>-<br>-<br>-|**Total**<br>**2023**<br>**£**<br>522|
|---|---|---|---|
||||**Total**<br>**2023**<br>**£**<br>4,713<br>(1)|
||||4,712|



Page 16 



## **Verity The Polycystic Ovaries Self Help Group** 

## **known as Verity** 

## **Notes to the Financial Statements for the Year Ended 31 March 2024** 

## **8 Expenditure on charitable activities** 

|**Note**<br>Direct costs<br>Insurance<br>Telephone and fax<br>Storage space<br>Computer software<br>and maintenance<br>costs<br>Printing, postage and<br>stationery<br>Sundry expenses<br>Travel and<br>subsistence<br>Legal and<br>professional fees<br>Computer software<br>and maintenance<br>costs<br>Just giving costs<br>Allocated support<br>costs<br>10<br>Governance costs<br>10|**Unrestricted**<br>**General**<br>**£**<br>7,000<br>817<br>773<br>1,888<br>304<br>3,651<br>7,217<br>8,793<br>14,689<br>420<br>216<br>-<br>9,519<br>55,287|**Restricted**<br>**£**<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>-<br>5,168<br>-<br>5,168|**Total**<br>**2024**<br>**£**<br>7,000<br>817<br>773<br>1,888<br>304<br>3,651<br>7,217<br>8,793<br>14,689<br>420<br>216<br>5,168<br>9,519<br>60,455|**Total**<br>**2023**<br>**£**<br>-<br>-<br>-<br>-<br>908<br>932<br>-<br>4,576<br>-<br>-<br>162<br>-<br>1,290|
|---|---|---|---|---|
|||||7,868|



In addition to the expenditure analysed above, there are also governance costs of £9,519 (2023 - £1,290) which relate directly to charitable activities. See note 10 for further details. 

Page 17 



## **Verity The Polycystic Ovaries Self Help Group** 

## **known as Verity** 

## **Notes to the Financial Statements for the Year Ended 31 March 2024** 

## **9 Other expenditure** 

## **Unrestricted** 

|**Note**<br>Allocated support costs|**General**<br>**£**<br>217<br>217|**Total**<br>**2024**<br>**£**<br>217<br>217|**Total**<br>**2023**<br>**£**<br>3,707|
|---|---|---|---|
||||3,707|



## **10Analysis of governance and support costs** 

## **Governance costs** 

## **Unrestricted** 

|Accountancy fees<br>Cost of trustee meetings<br>Travel cost of trustee meetings<br>**11Net incoming/outgoing resources**<br>Net incoming resources for the year include:<br>Revaluation of investment in subsidiary|**General**<br>**£**<br>2,422<br>3,228<br>3,869<br>9,519|**Total**<br>**2024**<br>**£**<br>2,422<br>3,228<br>3,869<br>9,519<br>**2024**<br>**£**<br>-|**Total**<br>**2023**<br>**£**<br>224<br>415<br>651|
|---|---|---|---|
||||1,290|
||||**2023**<br>**£**<br>(1)|



## **12Trustees remuneration and expenses** 

During the year the charity made the following transactions with Trustees: 

No Trustees, nor any persons connected with them, have received any remuneration from the charity during the year. 

Page 18 



## **Verity The Polycystic Ovaries Self Help Group** 

## **known as Verity** 

## **Notes to the Financial Statements for the Year Ended 31 March 2024** 

One Trustee received payment for specialist services in line with policy as a proportional investment in development. 

Any such payment must be approved by non conflicted trustees agreeing that securing the trustee's services is good value and in the best interests of the Charity. 

The amount paid to one Trustee for their specialist services in the period to 31st March 2024 was £10,920 [2023: £Nil]. The amounts paid are included in governance costs as professional fees. 

The amount of expenses paid to Trustees during the year totalled £8,530 (2023 - £7,792). 

## **13Taxation** 

The charity is a registered charity and is therefore exempt from taxation. 

## **14Fixed asset investments** 


**----- Start of picture text -----**<br>
2024 2023<br>£ £<br>Shares in group undertakings and participating interests 1 1<br>**----- End of picture text -----**<br>


## **Details of undertakings** 

Details of the investments in which the charity holds 20% or more of the nominal value of any class of share capital are as follows: 

||**Country of**||**Proportion of voting**|**Principal**|
|---|---|---|---|---|
|**Undertaking**|**incorporation**|**Holding**|**rights and shares held**|**activity**|
||||**2024**<br>**2023**||
|**Subsidiary undertakings**|||||
|PCOS UK Limited|England and<br>Wales|Ordinary|0%<br>100%|Health<br>advice<br>fundraising|



Page 19 



## **Verity The Polycystic Ovaries Self Help Group** 

## **known as Verity** 

## **Notes to the Financial Statements for the Year Ended 31 March 2024** 

## **15Debtors** 

|Trade debtors<br>Other debtors<br>**16Cash and cash equivalents**<br>Cash at bank<br>Short-term deposits|**2024**<br>**£**<br>30<br>-<br>30<br>**2024**<br>**£**<br>26,576<br>73,625<br>100,201|**2023**<br>**£**<br>10<br>1,619|
|---|---|---|
|||1,629|
|||**2023**<br>**£**<br>60,324<br>23,802|
|||84,126|



## **17Creditors: amounts falling due within one year** 

|Trade creditors<br>Accruals<br>**18Funds**<br>**Unrestricted funds**<br>General<br>**Restricted funds**<br>**Total funds**|**Balance at 1**<br>**April 2023**<br>**£**<br>60,489<br>22,737<br>83,226|**Incoming**<br>**resources**<br>**£**<br>14,829<br>60,020<br>74,849|**2024**<br>**£**<br>669<br>2,160<br>2,829<br>**Resources**<br>**expended**<br>**£**<br>(55,504)<br>(5,168)<br>(60,672)|**2023**<br>**£**<br>441<br>2,089|
|---|---|---|---|---|
|||||2,530|
|||||**Balance at**<br>**31 March**<br>**2024**<br>**£**<br>19,814<br>77,589|
|||||97,403|



Page 20 



## **Verity The Polycystic Ovaries Self Help Group** 

## **known as Verity** 

## **Notes to the Financial Statements for the Year Ended 31 March 2024** 

|**Unrestricted funds**<br>General<br>**Restricted funds**<br>**Total funds**|**Balance at 1**<br>**April 2022**<br>**£**<br>48,877<br>-<br>48,877|**Incoming**<br>**resources**<br>**£**<br>23,186<br>27,450<br>50,636|**Resources**<br>**expended**<br>**£**<br>(11,574)<br>(4,713)<br>(16,287)|**Balance at**<br>**31 March**<br>**2023**<br>**£**<br>60,489<br>22,737|
|---|---|---|---|---|
|||||83,226|



## **19Analysis of net assets between funds** 

|Fixed asset investments<br>Current assets<br>Current liabilities<br>Total net assets<br>Fixed asset investments<br>Current assets<br>Current liabilities<br>Total net assets|**Unrestricted**<br>**funds**<br>**General**<br>**£**<br>1<br>100,231<br>(2,829)<br>97,403<br>**Unrestricted**<br>**funds**<br>**General**<br>**£**<br>1<br>85,755<br>(2,530)<br>83,226|**Total funds**<br>**at 31 March**<br>**2024**<br>**£**<br>1<br>100,231<br>(2,829)|
|---|---|---|
|||97,403|
|||**Total funds**<br>**at 31 March**<br>**2023**<br>**£**<br>1<br>85,755<br>(2,530)|
|||83,226|



Page 21 



## **Verity The Polycystic Ovaries Self Help Group** 

## **known as Verity** 

## **Notes to the Financial Statements for the Year Ended 31 March 2024** 

## **20Analysis of net funds** 

|**20Analysis of net funds**|||
|---|---|---|
|Cash at bank and in hand<br>Net debt<br>Cash at bank and in hand<br>Net debt|**At 1 April**<br>**2023**<br>**£**<br>84,126<br>84,126<br>**At 1 April**<br>**2022**<br>**£**<br>44,950<br>44,950|**At 31 March**<br>**2024**<br>**£**<br>84,126|
|||84,126|
|||**At 31 March**<br>**2023**<br>**£**<br>44,950|
|||44,950|



Page 22 

